|
Volumn 92, Issue 5, 2020, Pages 461-463
|
The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019
|
Author keywords
COVID 19; lopinavir and ritonavir tablets; SARS CoV 2; severe respiratory syndrome
|
Indexed keywords
AMBROXOL;
C REACTIVE PROTEIN;
FIBRINOGEN;
LACTATE DEHYDROGENASE;
LOPINAVIR PLUS RITONAVIR;
METHYLPREDNISOLONE;
MOXIFLOXACIN;
RECOMBINANT ALPHA2B INTERFERON;
ACUTE HYPOXIC RESPIRATORY FAILURE;
ACUTE RESPIRATORY FAILURE;
ADULT;
CASE REPORT;
CHEST TIGHTNESS;
CHINA;
CLINICAL ARTICLE;
COMPUTER ASSISTED TOMOGRAPHY;
CORONAVIRUS DISEASE 2019;
CORONAVIRUS INFECTION;
COUGHING;
DIET;
DRUG DOSE REDUCTION;
DYSPNEA;
E GENE;
FATIGUE;
FEVER;
GENE EXPRESSION;
HUMAN;
LABORATORY TEST;
LETHARGY;
LETTER;
MALE;
MEDICAL HISTORY;
MIDDLE AGED;
N GENE;
NASOPHARYNGEAL SWAB;
NAUSEA;
OXYGEN THERAPY;
RDRP GENE;
REAL TIME POLYMERASE CHAIN REACTION;
RHINORRHEA;
SARS CORONAVIRUS;
SARS CORONAVIRUS 2;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
THORAX RADIOGRAPHY;
THROAT CULTURE;
TREATMENT OUTCOME;
VERTIGO;
VIRUS GENE;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
PNEUMONIA;
CHINA;
CORONAVIRUS INFECTIONS;
HUMANS;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
PNEUMONIA;
|
EID: 85080978164
PISSN: 01466615
EISSN: 10969071
Source Type: Journal
DOI: 10.1002/jmv.25711 Document Type: Letter |
Times cited : (119)
|
References (7)
|